人类遗传变异在SLC39A8的影响吸收和稳定状态金属水平在细胞内
Wen-An Wang1, Andrea Garofoli1, Evandro Ferrada2,3,4
1CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Life science alliance
|January 30, 2025
概括
人类的SLC39A8 (hSLC39A8) 基因
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 该SLC39A8 (hSLC39A8) 基因编码ZIP8蛋白,对于细胞吸收和等必需金属至关重要.
- 致病性hSLC39A8变异与糖化和李氏综合征的先天性疾病有关,但许多变异具有未知的意义.
- 了解hSLC39A8变体的影响对于诊断和潜在治疗金属平衡障碍至关重要.
研究的目的:
- 描述21种hSLC39A8变异对ZIP8蛋白位址和金属离子运输的功能影响.
- 为了研究这些变异如何影响,和的细胞内水平.
- 为了探索hSLC39A8变异的潜在的基因型-表型相关性.
主要方法:
- 局部定向的突变发生能产生21种hSLC39A8变种.
- 基于细胞的测试来评估蛋白质表达,内质网膜保留和血膜局部化.
- 使用ICP-MS.测量细胞内金属离子水平 (Cd2+, Zn2+, Mn2+) 的方法.
- 在蛋白质稳定性和同极体接口上的变异效应的分析.
主要成果:
- 四种变异影响了蛋白质表达,五种变异导致了内质网膜保留.
- 在血膜上局部化了12种变异,其中3种显示离子吸收完全丧失,5种显示不同金属离子输送.
- 在分析表明,一些变体可能会破坏ZIP8同极体接口的稳定性.
结论:
- hSLC39A8变种表现出多样化的功能后果,影响蛋白质表达,局部化和金属离子运输.
- 这些发现扩大了对ZIP8功能及其在金属平衡障碍中的作用的理解.
- 这项研究为进一步调查众多未表征hSLC39A8变异的临床相关性提供了基础.
相关概念视频
Translation
141.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.4K
Extraction: Advanced Methods
403
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
403


